Related references
Note: Only part of the references are listed.Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells
Thomas W. Grunt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Toshiro Migita et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells
Chi-Hung Huang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1
Eiji Furuta et al.
CANCER RESEARCH (2008)
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A. Vazquez-Martin et al.
CELL PROLIFERATION (2008)
Cohort Study of Fatty Acid Synthase Expression and Patient Survival in Colon Cancer
Shuji Ogino et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer
Michelangelo Fiorentino et al.
LABORATORY INVESTIGATION (2008)
Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes
Sabrina D. Silva et al.
VIRCHOWS ARCHIV (2008)
Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation
Chun-Te Chiang et al.
FEBS LETTERS (2007)
Up-regulation of Acetyl-CoA carboxylase α and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells
Sarah Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Key stages in mammary gland development - Secretory activation in the mammary gland: it's not just about milk protein synthesis!
Steven M. Anderson et al.
BREAST CANCER RESEARCH (2007)
Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake
Miguel Lopez et al.
BIOESSAYS (2007)
Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: A new family of anti-cancer agents?
Ruth Lupu et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2006)
Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer
DH Zhang et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells:: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
JA Menendez et al.
ANNALS OF ONCOLOGY (2005)
Targeting fatty acid synthase:: Potential for therapeutic intervention in Her-2/neu-: Overexpressing breast cancer
JA Menendez et al.
DRUG NEWS & PERSPECTIVES (2005)
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
JA Menendez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells
T Kusakabe et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
Share Paper
